|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...3738394041424344454647...110111» |
- Enrollment closed, Enrollment change, Trial primary completion date: Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=127, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
Recruiting --> Active, not recruiting | N=65 --> 127 | Trial primary completion date: Sep 2015 --> May 2015
- ||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion, Trial primary completion date: Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention (clinicaltrials.gov) - Oct 13, 2015
P=N/A, N=8000, Completed, Sponsor: Jhpiego
Recruiting --> Active, not recruiting | N=65 --> 127 | Trial primary completion date: Sep 2015 --> May 2015 Recruiting --> Completed | Trial primary completion date: Jun 2012 --> Nov 2012
- Trial completion, Trial primary completion date, HEOR: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer (clinicaltrials.gov) - Oct 9, 2015
P=N/A, N=39, Completed, Sponsor: Ohio State University Comprehensive Cancer Center
Recruiting --> Completed | Trial primary completion date: Jun 2012 --> Nov 2012 Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012
- | Lovaxin C (axalimogene filolisbac) / Ayala Pharma
Enrollment closed: Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer (clinicaltrials.gov) - Oct 8, 2015
P1/2, N=25, Active, not recruiting, Sponsor: Advaxis, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Jul 2015 --> Jan 2012 Recruiting --> Active, not recruiting
- clindamycin phosphate / Generic mfg.
Enrollment closed: Clindamycin to Reduce Preterm Birth in a Low Resource Setting (clinicaltrials.gov) - Oct 8, 2015
P4, N=1726, Active, not recruiting, Sponsor: Christiana Care Health Services
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || HSV vaccine (GEN-003) / Genocea, Shionogi
Trial primary completion date: Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Oct 7, 2015
P2, N=315, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Mar 2016
- metformin / Generic mfg.
Biomarker, Trial initiation date, Trial primary completion date: Endometrial Cancer Biomarker Changes Following Exposure to Metformin (clinicaltrials.gov) - Oct 7, 2015
P2, N=80, Not yet recruiting, Sponsor: Jewish General Hospital
Trial primary completion date: Jun 2015 --> Mar 2016 Initiation date: Mar 2014 --> Mar 2016 | Trial primary completion date: Dec 2015 --> Dec 2017
- metformin / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Enrollment open, Trial initiation date, Combination therapy, Metastases: OVMET: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer (clinicaltrials.gov) - Oct 7, 2015
P1, N=20, Recruiting, Sponsor: University Medical Center Groningen
Initiation date: Mar 2014 --> Mar 2016 | Trial primary completion date: Dec 2015 --> Dec 2017 Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Oct 2015
- Trial completion: Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=1000, Completed, Sponsor: Sihanouk Hospital Center of HOPE
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Oct 2015 Not yet recruiting --> Completed
- |||| selurampanel (BGG492) / Novartis
Trial completion, Enrollment change, Trial primary completion date: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) - Oct 7, 2015
P2, N=59, Completed, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Completed Recruiting --> Completed | N=77 --> 59 | Trial primary completion date: Jun 2015 --> Sep 2015
- New trial, Preclinical: Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=800, Not yet recruiting, Sponsor: The University of Hong Kong
- | sildenafil cream (SST-6006) / Daré Biosci, Strategic Science & Technologies
New P2a trial: Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder (clinicaltrials.gov) - Oct 7, 2015
P2a, N=30, Recruiting, Sponsor: Strategic Science & Technologies, LLC
- topotecan / Generic mfg., acetylcysteine solution / Generic mfg.
Biomarker, New P2 trial, Tumor microenvironment: Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Oct 7, 2015
P2, N=48, Recruiting, Sponsor: Thomas Jefferson University
- Trial completion, Enrollment change: Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=16, Completed, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Completed | N=77 --> 59 | Trial primary completion date: Jun 2015 --> Sep 2015 Active, not recruiting --> Completed | N=20 --> 16
- || varlilumab (CDX 1127) / Celldex
Enrollment closed, Enrollment change, Trial primary completion date: A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers (clinicaltrials.gov) - Oct 6, 2015
P1, N=90, Active, not recruiting, Sponsor: Celldex Therapeutics
Active, not recruiting --> Completed | N=20 --> 16 Recruiting --> Active, not recruiting | N=170 --> 90 | Trial primary completion date: Sep 2015 --> Dec 2015
- metformin / Generic mfg.
New P4 trial: The Effect of Metformin on Different Hormones in PCOS Patients (clinicaltrials.gov) - Oct 6, 2015
P4, N=48, Completed, Sponsor: Ahmed Maged
- New trial: Database of Pelvic Inflammatory Disease (clinicaltrials.gov) - Oct 5, 2015
P=N/A, N=200, Recruiting, Sponsor: Kangbuk Samsung Hospital
- || New P3 trial: Lidocaine Gel During Transrectal Sonography (clinicaltrials.gov) - Oct 5, 2015
P3, N=80, Recruiting, Sponsor: Kangbuk Samsung Hospital
- Talzenna (talazoparib) / Pfizer
New P1 trial, PARP Biomarker, Surgery, Metastases: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (clinicaltrials.gov) - Oct 5, 2015
P1, N=105, Not yet recruiting, Sponsor: National Cancer Institute (NCI)
- Trial primary completion date: eSiHLE: e-SiHLE: An Internet Pregnancy Prevention for Older Teenage Girls (clinicaltrials.gov) - Oct 3, 2015
P=N/A, N=700, Active, not recruiting, Sponsor: Tulane University Health Sciences Center
Recruiting --> Active, not recruiting | N=170 --> 90 | Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Jun 2015 --> Oct 2015
- Trial completion, Preclinical, Enrollment change, Trial primary completion date: Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation (clinicaltrials.gov) - Oct 3, 2015
P1/2, N=80, Completed, Sponsor: National and Kapodistrian University of Athens
Trial primary completion date: Jun 2015 --> Oct 2015 Recruiting --> Completed | N=50 --> 80 | Trial primary completion date: Dec 2015 --> Sep 2015
- Trial primary completion date, HEOR: Sexual Functioning in Cervical Cancer Survivors (clinicaltrials.gov) - Oct 3, 2015
P=N/A, N=165, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed | N=50 --> 80 | Trial primary completion date: Dec 2015 --> Sep 2015 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion: Zinc Supplements in Lowering Cadmium Levels in Smokers (clinicaltrials.gov) - Oct 3, 2015
P2, N=61, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Trial primary completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Completed
- Trial primary completion date: Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial (clinicaltrials.gov) - Oct 3, 2015
P2/3, N=80, Recruiting, Sponsor: Benha University
Active, not recruiting --> Completed Trial primary completion date: Aug 2015 --> Dec 2015
- calcium dobesilate monohydrate / Generic mfg.
Trial primary completion date: Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Oct 3, 2015
P2/3, N=210, Recruiting, Sponsor: khalid abd aziz mohamed
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Aug 2015 --> Nov 2015
- cabergoline / Generic mfg., calcium dobesilate monohydrate / Generic mfg.
Trial primary completion date: Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Oct 3, 2015
P2/3, N=220, Recruiting, Sponsor: Benha University
Trial primary completion date: Aug 2015 --> Nov 2015 Trial primary completion date: Jul 2015 --> Nov 2015
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Vaginal Creams to Reduce Vaginal Erosion in Pessary Users (clinicaltrials.gov) - Oct 3, 2015
P2, N=0, Withdrawn, Sponsor: North Shore Long Island Jewish Health System
Trial primary completion date: Jul 2015 --> Nov 2015 N=246 --> 0 | Initiation date: Jan 2015 --> Apr 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2015 --> Aug 2015
- Enrollment change, Trial primary completion date: Hysteroscopic Assessment of Fallopian Tubal Patency (clinicaltrials.gov) - Oct 3, 2015
P=N/A, N=1000, Recruiting, Sponsor: University of Mississippi Medical Center
N=246 --> 0 | Initiation date: Jan 2015 --> Apr 2015 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2015 --> Aug 2015 N=500 --> 1000 | Trial primary completion date: Apr 2016 --> Nov 2016
- Enrollment closed, Preclinical: An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro (clinicaltrials.gov) - Oct 3, 2015
P=N/A, N=100, Active, not recruiting, Sponsor: National Foundation for Fertility Research
N=500 --> 1000 | Trial primary completion date: Apr 2016 --> Nov 2016 Recruiting --> Active, not recruiting
- clomifene citrate / Generic mfg.
Trial primary completion date: Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Oct 2, 2015
P2/3, N=160, Recruiting, Sponsor: Benha University
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2015 --> Dec 2015
- || Hepacid (pegargiminase) / Polaris Pharma
Trial primary completion date, Metastases: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma (clinicaltrials.gov) - Oct 2, 2015
P1, N=89, Recruiting, Sponsor: Polaris Group
Trial primary completion date: Aug 2015 --> Dec 2015 Trial primary completion date: Dec 2015 --> Nov 2016
- Trial primary completion date: SUCCESS: Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=600, Active, not recruiting, Sponsor: University of Miami
Trial primary completion date: Dec 2015 --> Nov 2016 Trial primary completion date: Aug 2015 --> Aug 2016
- Trial primary completion date: DNA Array Analysis of Patients With Cervical Cancer (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=18, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Aug 2015 --> Aug 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial primary completion date: Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy (clinicaltrials.gov) - Oct 1, 2015
P1/2, N=24, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Sep 2016 --> Sep 2017
- Enrollment closed: Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=250, Active, not recruiting, Sponsor: Herlev Hospital
Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Active, not recruiting
- | Enrollment closed, Trial primary completion date: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Oct 1, 2015
P3, N=368, Active, not recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Feb 2016
- Trial completion: GPs: Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=53978, Completed, Sponsor: University Hospital, Tours
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Feb 2016 Active, not recruiting --> Completed
- carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients (clinicaltrials.gov) - Oct 1, 2015
P1, N=65, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=64, Recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Aug 2016
- Trial completion, Enrollment change: Infertility Markers in Serum, Urine, and Follicular Fluid (clinicaltrials.gov) - Oct 1, 2015
P=N/A, N=1235, Completed, Sponsor: University of Pennsylvania
Trial primary completion date: Feb 2016 --> Aug 2016 Recruiting --> Completed | N=1000 --> 1235
- ||| TroVax (MVA 5T4) / Oxford Biomedica
Enrollment change: TRIOC: The Activity of TroVax (clinicaltrials.gov) - Sep 30, 2015
P2, N=75, Recruiting, Sponsor: University College, London
Recruiting --> Completed | N=1000 --> 1235 N=100 --> 75
- || New P3 trial: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer (clinicaltrials.gov) - Sep 30, 2015
P3, N=114, Not yet recruiting, Sponsor: Centre hospitalier de l'Universit
- || trebananib (AMG 386) / Amgen
Trial primary completion date, Combination therapy, Metastases: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR (clinicaltrials.gov) - Sep 29, 2015
P1, N=103, Completed, Sponsor: Amgen
N=100 --> 75 Trial primary completion date: Apr 2012 --> Jan 2012
- |||||||||| New P3 trial: A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (clinicaltrials.gov) - Sep 29, 2015
P3, N=975, Not yet recruiting, Sponsor: Jun Zhang
- New P2 trial: Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer (clinicaltrials.gov) - Sep 29, 2015
P2, N=43, Recruiting, Sponsor: Shanghai Gynecologic Oncology Group
- Avastin (bevacizumab) / Roche
Trial primary completion date: Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers (clinicaltrials.gov) - Sep 28, 2015
P2, N=21, Completed, Sponsor: Dana-Farber Cancer Institute
Trial primary completion date: Apr 2012 --> Jan 2012 Trial primary completion date: Feb 2012 --> Nov 2010
- pegylated liposomal doxorubicin / Generic mfg., carboplatin / Generic mfg.
Enrollment change, Trial termination: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma (clinicaltrials.gov) - Sep 28, 2015
P2, N=34, Terminated, Sponsor: Hellenic Oncology Research Group
Trial primary completion date: Feb 2012 --> Nov 2010 N=100 --> 34 | Withdrawn --> Terminated; Poor accrual
- Trial primary completion date: Risk of Diabetes in Young Turner Syndrome Patients (clinicaltrials.gov) - Sep 28, 2015
P=N/A, N=120, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
N=100 --> 34 | Withdrawn --> Terminated; Poor accrual Trial primary completion date: Sep 2015 --> Dec 2015
- Enrollment change, Trial withdrawal, Trial primary completion date, MRI: MILO: Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer (clinicaltrials.gov) - Sep 28, 2015
P4, N=0, Withdrawn, Sponsor: Maastricht University Medical Center
Trial primary completion date: Sep 2015 --> Dec 2015 N=20 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2015 --> Sep 2014
- New trial: BRO: Being Responsible for Ourselves HIV Risk Reduction for Black MSM (clinicaltrials.gov) - Sep 28, 2015
P=N/A, N=595, Completed, Sponsor: University of Pennsylvania